Insider Selling: Docusign (NASDAQ:DOCU) Director Sells 365 Shares of Stock

Docusign Inc. (NASDAQ:DOCU) Director Anna Marrs sold 365 shares of the firm’s stock in a transaction dated Tuesday, June 2nd. The stock was sold at an average price of $55.04, for a total value of $20,089.60. Following the completion of the sale, the director directly owned 12,615 shares in the company, valued at approximately $694,329.60. The trade was a 2.81% decrease in their ownership of the stock. The sale was disclosed in a legal filing with the SEC, which can be accessed through this link. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan.

Anna Marrs also recently made the following trade(s):

• On Thursday, March 5th, Anna Marrs sold 363 shares of Docusign stock. The stock was sold at an average price of $46.33, for a total value of $16,817.79.

Docusign Price Performance

NASDAQ:DOCU traded down $1.92 during mid-day trading on Tuesday, reaching $55.10. The company’s stock had a trading volume of 4,876,948 shares, compared to its average volume of 4,341,708. The company’s fifty day simple moving average is $47.41 and its two-hundred day simple moving average is $54.53. Docusign Inc. has a twelve month low of $40.16 and a twelve month high of $94.67. The stock has a market cap of $10.71 billion, a P/E ratio of 37.23, a P/E/G ratio of 2.01 and a beta of 0.88.

Docusign (NASDAQ:DOCU) last issued its quarterly earnings results on Tuesday, March 17th. The company reported $1.01 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.95 by $0.06. The firm had revenue of $836.86 million for the quarter, compared to analyst estimates of $828.23 million. Docusign had a return on equity of 16.86% and a net margin of 9.60%.The firm’s quarterly revenue was up 7.8% on a year-over-year basis. During the same period last year, the company earned $0.86 EPS. Sell-side analysts expect that Docusign Inc. will post 1.75 EPS for the current fiscal year.

Docusign declared that its board has approved a share repurchase program on Tuesday, March 17th that permits the company to repurchase $2.00 billion in outstanding shares. This repurchase authorization permits the company to repurchase up to 21% of its stock through open market purchases. Stock repurchase programs are generally an indication that the company’s board of directors believes its stock is undervalued.

Wall Street Analyst Weigh In

A number of research firms have recently commented on DOCU. Bank of America began coverage on Docusign in a report on Tuesday, March 31st. They issued an “underperform” rating and a $52.00 price objective on the stock. Royal Bank Of Canada cut their price objective on Docusign from $70.00 to $55.00 and set a “sector perform” rating on the stock in a report on Wednesday, March 18th. BTIG Research restated a “buy” rating and issued a $70.00 price objective on shares of Docusign in a report on Wednesday, March 18th. Weiss Ratings downgraded Docusign from a “hold (c-)” rating to a “sell (d+)” rating in a report on Wednesday, April 15th. Finally, Citigroup downgraded Docusign from a “buy” rating to a “neutral” rating and cut their price objective for the stock from $99.00 to $50.00 in a report on Friday, April 10th. Three investment analysts have rated the stock with a Buy rating, fourteen have assigned a Hold rating and two have issued a Sell rating to the company. According to data from MarketBeat.com, Docusign has an average rating of “Hold” and an average price target of $61.40.

More Docusign News

Here are the key news stories impacting Docusign this week:

• Positive Sentiment: Docusign announced its app is now available in ChatGPT and Codex, extending its Intelligent Agreement Management platform into OpenAI products and potentially boosting adoption by making it easier for customers to create, analyze, and manage agreements with natural-language prompts. Docusign Brings Trusted Agreement Intelligence and Workflows into ChatGPT and Codex
• Positive Sentiment: The company also named Graham Sheldon as Chief Product Officer, a move aimed at accelerating its AI-focused product strategy and strengthening execution around its Intelligent Agreement Management vision. Docusign Appoints Graham Sheldon as Chief Product Officer to Accelerate Intelligent Agreement Management Vision
• Neutral Sentiment: Several directors disclosed stock sales, including Anna Marrs, James A. Beer, and Teresa Briggs. The transactions were relatively small and were executed under pre-arranged Rule 10b5-1 plans, which usually makes them less concerning for investors. SEC filing: Anna Marrs Form 4
• Neutral Sentiment: Investor attention is also focused on Docusign’s June 4 earnings report, with recent commentary suggesting the market wants proof that its AI-driven product strategy is translating into stronger execution. Dear Docusign Stock Fans, Mark Your Calendars for June 4

Institutional Investors Weigh In On Docusign

Several hedge funds have recently modified their holdings of DOCU. Norges Bank purchased a new stake in shares of Docusign during the 4th quarter valued at about $186,795,000. Arrowstreet Capital Limited Partnership raised its holdings in shares of Docusign by 76.1% during the 1st quarter. Arrowstreet Capital Limited Partnership now owns 5,285,128 shares of the company’s stock valued at $250,568,000 after buying an additional 2,283,996 shares during the period. Capital World Investors raised its holdings in shares of Docusign by 38.1% during the 4th quarter. Capital World Investors now owns 5,815,804 shares of the company’s stock valued at $397,801,000 after buying an additional 1,603,900 shares during the period. SG Americas Securities LLC raised its holdings in shares of Docusign by 452.3% during the 1st quarter. SG Americas Securities LLC now owns 1,314,632 shares of the company’s stock valued at $62,327,000 after buying an additional 1,076,622 shares during the period. Finally, Woodline Partners LP raised its holdings in shares of Docusign by 24,412.7% during the 3rd quarter. Woodline Partners LP now owns 958,938 shares of the company’s stock valued at $69,130,000 after buying an additional 955,026 shares during the period. 77.64% of the stock is currently owned by hedge funds and other institutional investors.

About Docusign

DocuSign, Inc (NASDAQ: DOCU) is a leading provider of electronic signature and digital transaction management solutions. The company’s flagship offering, DocuSign eSignature, enables organizations to send, sign and manage legally binding electronic agreements securely in the cloud. Beyond eSignature, DocuSign’s Agreement Cloud combines contract lifecycle management, document generation, and workflow automation to streamline agreement processes from initiation through execution and storage.

DocuSign’s platform serves a diverse customer base spanning industries such as finance, real estate, healthcare, technology, and government.